AUPH · Aurinia Pharmaceuticals Inc. · Executive Compensation

$16.56 +0.42 (+2.60%) At close · Nov 3 Play latest call Q4 2025 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$2.22B

134.00M

Volume · Nov 3 1.18M Avg daily vol (3M) 922.18K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Greenleaf	Former Chief Executive Officer	$822,877	—	$1,965,321	$2,193,189	$864,021	$13,182	$5,858,590
Matthew Donley	Former Chief Operating Officer	$567,636	—	$559,600	$624,484	$425,727	$59,641	$2,237,088
Stephen Robertson	Chief Legal Officer, Corporate Secretary and Chief Compliance Officer	$481,900	—	$568,557	$634,473	$361,425	$80,155	$2,126,510
Joseph Miller	Former Chief Financial Officer	$526,988	—	$550,649	$614,491	$395,241	$15,378	$2,102,747
Gregory Keenan	Former Chief Medical Officer	$516,233	—	$423,060	$472,108	$348,458	$14,382	$1,774,241

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Greenleaf	Chief Executive Officer	$822,877	—	$4,825,917	—	$720,017	$49,086	$6,417,897
Matthew Donley	Former Chief Operating Officer	$539,321	—	$1,580,576	—	$337,076	$57,554	$2,514,527
Max Donley	Chief Operating Officer	$539,321	—	$1,580,576	—	$337,076	$57,554	$2,514,527
Joseph Miller	Former Chief Financial Officer	$500,701	—	$1,430,935	—	$312,938	$53,231	$2,297,805
Joe Miller	Chief Financial Officer	$500,701	—	$1,430,935	—	$312,938	$53,231	$2,297,805
Stephen Robertson	EVP, General Counsel, Corporate Secretary and Chief Compliance Officer	$471,702	—	$1,416,911	—	$294,814	$33,002	$2,216,429
Gregory Keenan	Former Chief Medical Officer	$495,187	—	$547,983	—	$278,543	$5,384	$1,327,097
Greg Keenan	Chief Medical Officer	$495,187	—	$547,983	—	$278,543	$5,384	$1,327,097

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Greenleaf	Chief Executive Officer	$822,877	—	$8,999,997	—	$710,760	$39,725	$10,573,359
Matthew Donley	Former Chief Operating Officer	$513,640	—	$3,656,242	—	$341,571	$46,633	$4,558,086
Max Donley	Chief Operating Officer	$513,640	—	$3,656,242	—	$341,571	$46,633	$4,558,086
Joe Miller	Chief Financial Officer	$500,701	—	$3,093,747	—	$342,980	$39,509	$3,976,937
Joseph Miller	Former Chief Financial Officer	$500,701	—	$3,093,747	—	$342,980	$39,509	$3,976,937
Stephen Robertson	EVP, General Counsel, Corporate Secretary and Chief Compliance Officer	$478,727	—	$2,761,872	—	$327,928	$29,727	$3,598,254
Volker Knappertz	EVP, Research and Development	$516,250	—	$2,581,865	—	$327,819	$10,540	$3,436,474
Gregory Keenan	Former Chief Medical Officer	$400,232	—	$450,039	$453,710	$218,706	$9,010	$1,531,697
Greg Keenan	Chief Medical Officer	$400,232	—	$450,039	$453,710	$218,706	$9,010	$1,531,697

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Greenleaf	Chief Executive Officer	$791,228	—	$3,750,002	$3,752,009	$498,474	$45,684	$8,837,397
Max Colao	Former Chief Commercial Officer	$274,970	—	$1,250,001	$1,250,672	$244,417	$582,942	$3,603,002
Max Donley	Chief Operating Officer	$493,885	—	$1,250,001	$1,250,672	$271,637	$46,302	$3,312,497
Joe Miller	Chief Financial Officer	$481,443	—	$1,250,001	$1,250,672	$264,794	$45,684	$3,292,594
Stephen Robertson	EVP, General Counsel, Corporate Secretary and Chief Compliance Officer	$458,696	—	$1,250,001	$1,250,672	$252,283	$28,703	$3,240,355
Neil Solomons	Former Chief Medical Officer	$369,021	—	$875,001	$875,470	$221,413	$881,223	$3,222,128
Volker Knappertz	EVP, Research and Development	$229,167	—	$1,250,002	$1,249,337	$250,000	$5,180	$2,983,686
Scott Habig	Former Chief Commercial Officer	$206,250	$100,000	$1,125,004	$1,124,999	$225,000	$4,493	$2,785,746
Greg Keenan	Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Greenleaf	Chief Executive Officer	$723,905	—	—	—	$506,734	$10,182	$1,240,821
Max Donley	EVP, Operations and Strategy	$448,986	—	—	—	$269,392	$12,260	$730,638
Stephen Robertson	EVP, General Counsel, Corporate Secretary and Chief Compliance Officer	$448,373	—	—	—	$252,209	$22,108	$722,690
Neil Solomons	Former Chief Medical Officer	$442,164	—	—	—	$248,717	$26,443	$717,324
Joe Miller	Chief Financial Officer	$437,675	—	—	—	$262,605	$10,185	$710,465
Max Colao	Former Chief Commercial Officer	$459,000	—	—	—	$240,975	$10,182	$710,157
Volker Knappertz	EVP, Research and Development	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Greenleaf	Chief Executive Officer	$673,400	—	$1,534,992	$7,753,906	$707,070	$9,914	$10,679,282
Max Colao	Former Chief Commercial Officer	$354,167	$153,125	$461,040	$3,664,488	$212,500	$580	$4,845,900
Joe Miller	Chief Financial Officer	$279,545	$162,898	$461,040	$2,639,722	$167,727	$4,280	$3,715,212
Stephen Robertson	EVP, General Counsel, Corporate Secretary and Chief Compliance Officer	$73,752	$75,684	$461,040	$2,907,909	$46,006	$2,472	$3,566,863
Max Donley	EVP, Operations and Strategy	$383,320	—	$461,040	$2,249,253	$239,575	$5,029	$3,338,217
Neil Solomons	Former Chief Medical Officer	$402,148	—	$461,040	$1,842,476	$251,343	$20,327	$2,977,334
Dennis Bourgeault	Former Chief Financial Officer	$88,426	—	—	$399,825	$121,992	$93,472	$703,715
Volker Knappertz	EVP, Research and Development	—	—	—	—	—	—	—

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Peter Greenleaf	Chief Executive Officer	$438,258	$250,000	—	$4,176,172	$368,137	$4,063	$5,236,630
Max Donley	EVP, Operations and Strategy	$168,299	—	—	$598,154	$177,600	$1,850	$945,903
Dennis Bourgeault	Former Chief Financial Officer	$270,145	—	—	$180,784	$126,205	$3,713	$580,847
Joe Miller	Chief Financial Officer	—	—	—	—	—	—	—
Stephen Robertson	EVP, General Counsel, Corporate Secretary and Chief Compliance Officer	—	—	—	—	—	—	—
Max Colao	Chief Commercial Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dennis Bourgeault	Former Chief Financial Officer	$242,969	—	—	$351,432	$86,220	—	$680,621
Max Colao	Chief Commercial Officer	—	—	—	—	—	—	—
Stephen Robertson	EVP, General Counsel, Corporate Secretary and Chief Compliance Officer	—	—	—	—	—	—	—
Joe Miller	Chief Financial Officer	—	—	—	—	—	—	—
Peter Greenleaf	Chief Executive Officer	—	—	—	—	—	—	—
Max Donley	EVP, Operations and Strategy	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Craig Johnson	Lead Independent Director	Appointed	2026-03-21	2026-03-23
Peter Greenleaf	Director	Resigned	2026-03-21	2026-03-23
Michael Hearne	Chief Financial Officer	Appointed	2026-03-23	2026-03-23
Ryan Cole	Chief Operating Officer	Appointed	2026-03-23	2026-03-23
Kevin Tang	Chief Executive Officer	Appointed	2026-03-23	2026-03-23
Craig Johnson	members of the Company's board of directors	Appointed	2025-05-15	2025-05-15
Tina S. Nova	members of the Company's board of directors	Appointed	2025-05-15	2025-05-15
Kathy L. Goetz	members of the Company's board of directors	Appointed	2025-05-15	2025-05-15
Peter Greenleaf	members of the Company's board of directors	Appointed	2025-05-15	2025-05-15
Jeffrey A. Bailey	members of the Company's board of directors	Appointed	2025-05-15	2025-05-15
Kevin Tang	members of the Company's board of directors	Appointed	2025-05-15	2025-05-15
Robert T. Foster	Board	Retired	2024-11-05	2024-11-07
Craig Johnson	Board of Directors	Appointed	2024-11-07	2024-11-07
Scott Habig	Chief Commercial Officer	Terminated	—	2024-11-07
Daniel G. Billen	Director	Resigned	—	2024-09-12
R. Hector MacKay-Dunn	Director	Resigned	—	2024-09-12
Brinda Balakrishnan	Director	Resigned	—	2024-09-12
Kevin Tang	Director	Appointed	—	2024-09-12
Kevin Tang	member of the Board	Appointed	2024-09-12	2024-09-12
R. Hector MacKay-Dunn	director	Resigned	2024-09-09	2024-09-12
Brinda Balakrishnan	director	Resigned	2024-09-09	2024-09-12
Daniel G. Billen	director	Resigned	2024-09-09	2024-09-12
Dr. Volker Knappertz	Executive Vice President, Research and Development	Terminated	—	2024-02-29
Dr. Robert T. Foster	Director	Appointed	—	2023-09-21
Dr. Robert T. Foster	member of the Board of Directors	Appointed	2023-09-21	2023-09-21

Leadership

Jeffrey Bailey CEO, Board Member
Kevin Tang CEO, Board Member
Peter Greenleaf CEO, Board Member
Joseph Miller CFO
Michael Hearne CFO
Matthew Donley COO
Ryan Cole COO
Stephen Robertson General Counsel
Craig Johnson Board Member
Dr. Karen Smith Board Member
Dr. Robert T. Foster Board Member
Jeffrey A. Bailey Board Member
Kathy Goetz Board Member
Kathy L. Goetz Board Member
Tina S. Nova Board Member

Key facts CIK 1600620 CUSIP 05156V102 13F (30d) 91 filings 79 filers Visit website Investor relations